NYSE · Healthcare
STERIS plc (STE)
As-reported financials and recent SEC filings for STERIS plc, latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.94B
Net income
$782.3M
Net margin
13.2%
Diluted EPS
$7.93
ROE
10.9%
P/E (TTM)
27.2×
Market cap
$21.02B
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B |
| Gross profit | $2.63B | $2.40B | $2.22B | $1.98B | $1.88B |
| Operating income | $1.10B | $866.6M | $836.1M | $791.1M | $477.8M |
| Net income | $782.3M | $614.6M | $378.2M | $107.0M | $243.9M |
| Diluted EPS | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
11-K2026-06-16
View on EDGAR →42026-06-16
View on EDGAR →1442026-06-15
View on EDGAR →ARS2026-06-11
View on EDGAR →DEFA14A2026-06-11
View on EDGAR →DEF 14A2026-06-11
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →Go deeper on STE
Search STERIS plc’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.